DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+13.75%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.18B
AUM Growth
+$2.18B
(+23%)
Cap. Flow
+$262M
Cap. Flow
% of AUM
12.01%
Top 10 Holdings %
Top 10 Hldgs %
32.65%
Holding
150
New
47
Increased
20
Reduced
25
Closed
28
Top Buys
| 1 |
Labcorp
LH
|
$69.7M |
| 2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$68.6M |
| 3 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$61.2M |
| 4 |
ITMN
INTERMUNE INC
ITMN
|
$53M |
| 5 |
AbbVie
ABBV
|
$52.7M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$50.3M |
| 2 |
Humana
HUM
|
$42.8M |
| 3 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$42M |
| 4 |
Globus Medical
GMED
|
$34.2M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$30.3M |
Sector Composition
| 1 | Healthcare | 49.23% |
| 2 | Technology | 1.36% |
| 3 | Financials | 0.63% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
51
DELISTED
bluebird bio
BLUE
| $9.43M | 0.38% | 414,474 -8,750 | -2% | -$199K |
|
|
ELGX
52
DELISTED
Endologix Inc
ELGX
| $8.8M | 0.36% | +683,458 | New | +$8.8M |
|
|
CNCE
53
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $8.31M | 0.34% | +617,649 | New | +$8.31M |
|
54
PTC Therapeutics
PTCT
$3.92B
| $8.3M | 0.34% | 317,530 -227,497 | -42% | -$5.95M |
|
55
Vanda Pharmaceuticals
VNDA
$279M
| $8.15M | 0.33% | 501,709 -129,567 | -21% | -$2.11M |
|
|
NSTG
56
DELISTED
NanoString Technologies, Inc.
NSTG
| $8.08M | 0.33% | 391,105 -233,606 | -37% | -$4.82M |
|
57
Sonida Senior Living
SNDA
$488M
| $8.01M | 0.33% | 308,088 -1,110,023 | -78% | -$28.8M |
|
|
WINT
58
DELISTED
Windtree Therapeutics Inc
WINT
| $7.87M | 0.32% | 3,659,700 | – | – |
|
59
Centene
CNC
$14.3B
| $7.77M | 0.32% | 124,795 -188,017 | -60% | -$11.7M |
|
|
ARNA
60
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $7.66M | 0.31% | 1,216,579 | – | – |
|
|
KBIO
61
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $7.55M | 0.31% | +2,786,783 | New | +$7.55M |
|
|
CASM
62
DELISTED
CAS Medical Systems, Inc.
CASM
| $6.94M | 0.28% | 3,200,000 | – | – |
|
|
AMED
63
DELISTED
Amedisys
AMED
| $6.54M | 0.27% | +439,000 | New | +$6.54M |
|
64
Baxter International
BAX
$12.7B
| $6.25M | 0.26% | 85,000 -17,500 | -17% | -$1.29M |
|
65
Alphatec Holdings
ATEC
$2.35B
| $5.97M | 0.24% | 3,982,738 | – | – |
|
66
Inogen
INGN
$216M
| $5.9M | 0.24% | +357,269 | New | +$5.9M |
|
|
STRM
67
DELISTED
Streamline Health Solutions
STRM
| $5.74M | 0.23% | 1,140,100 +815,100 | +251% | +$4.1M |
|
|
ANTH
68
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $5.67M | 0.23% | 1,691,857 | – | – |
|
69
Vertex Pharmaceuticals
VRTX
$100B
| $5.55M | 0.23% | +78,500 | New | +$5.55M |
|
70
uniQure
QURE
$896M
| $5.45M | 0.22% | +350,000 | New | +$5.45M |
|
|
VYNT
71
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $4.8M | 0.2% | 318,012 -36,168 | -10% | -$546K |
|
|
LPDX
72
DELISTED
LIPOSCIENCE INC COM
LPDX
| $4.41M | 0.18% | 1,382,350 | – | – |
|
|
NSPH
73
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $4.3M | 0.18% | 2,000,000 -2,746,913 | -58% | -$5.91M |
|
74
Rigel Pharmaceuticals
RIGL
$697M
| $3.99M | 0.16% | 1,027,443 +263,768 | +35% | +$1.02M |
|
|
DSCI
75
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $3.8M | 0.16% | +300,000 | New | +$3.8M |
|